A. Borisy
Molecular Biology · 2003–2009
A researcher in the Science corpus: 3 papers; trusts 1 researcher and is trusted by 1 researcher here, as inferred from the citation graph.
Subfields
- Molecular Biology — 23 citations into it; #16,647 of 17,773 by trust here, #6,893 by citations
Whom A. Borisy trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts A. Borisy overall
Papers from A. Borisy's perspective
Ordered by how strongly the researchers A. Borisy trusts endorse each paper. Same corpus, a different order for every researcher.
- The problem of synergism and antagonism of combined drugs.
- Identifying regulatory networks by combinatorial analysis of promoter elements (Nature Genetics)
- Computational modeling of the dynamics of the MAP kinase cascade activated by surface and internalized EGF receptors (Nature Biotechnology)
- The Concept of Synthetic Lethality in the Context of Anticancer Therapy (Nature Reviews. Cancer)
- Multi-target therapeutics: when the whole is greater than the sum of the parts. (Drug Discovery Today)
- Systems Biology: A Brief Overview (Science)
- On the allelic spectrum of human disease. (Trends in Genetics)
- A new approach to decoding life: systems biology. (Annual review of genomics and human genetics (Print))
- The HUPO PSI's Molecular Interaction format—a community standard for the representation of protein interaction data (Nature Biotechnology)
- An automated method for finding molecular complexes in large protein interaction networks (BMC Bioinformatics)
Their papers
- Systematic discovery of multicomponent therapeutics (2003) — 610 citations
- Multicomponent therapeutics for networked systems (2005) — 758 citations
- Synergistic drug combinations improve therapeutic selectivity (2009) — 611 citations